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Abstract
Mutations in the GJB2 gene, which encodes connexin 26, are a frequent cause of congenital non-syndromic sensorineural
hearing loss. Two large deletions, del(GJB6-D13S1830) and del(GJB6-D13S1854), which truncate GJB6 (connexin 30), cause
hearing loss in individuals homozygous, or compound heterozygous for these deletions or one such deletion and a
mutation in GJB2. Recently, we have demonstrated that the del(GJB6-D13S1830) deletion contributes to hearing loss due to
an allele-specific lack of GJB2 mRNA expression and not as a result of digenic inheritance, as was postulated earlier. In the
current study we investigated the smaller del(GJB6-D13S1854) deletion, which disrupts the expression of GJB2 at the
transcriptional level in a manner similar to the more common del(GJB6-D13S1830) deletion. Interestingly, in the presence of
this deletion, GJB2 expression remains minimally but reproducibly present. The relative allele-specific expression of GJB2
was assessed by reverse-transcriptase PCR and restriction digestions in three probands who were compound heterozygous
for a GJB2 mutation and del(GJB6-D13S1854). Each individual carried a different sequence variant in GJB2. All three
individuals expressed the mutated GJB2 allele in trans with del(GJB6-D13S1854), but expression of the GJB2 allele in cis with
the deletion was almost absent. Our study clearly corroborates the hypothesis that the del(GJB6-D13S1854), similar to the
larger and more common del(GJB6-D13S1830), removes (a) putative cis-regulatory element(s) upstream of GJB6 and narrows
down the region of location.
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Introduction
The DFNB1 locus at chromosome 13q11-q12 includes the
GJB2 and GJB6 genes, which respectively encode connexin 26
(Cx26) and connexin 30 (Cx30). These connexin proteins are co-
expressed and co-localized in the cochlea, where they create
heteromeric gap junctions [1] and make important contributions
to cochlear homeostasis [2]. GJB2 mutations are the most
common genetic etiology of prelingual non-syndromic sensori-
neural hearing loss [3,4]. Even though many recessive GJB2
mutations have been described (http://davinci.crg.es/deafness/),
so far only four recessive mutations affecting GJB6 or the region
upstream have been reported, all of which are deletions [5–12]
(Fig 1). The most common are del(GJB6-D13S1830) and
del(GJB6-D13S1854), which truncate the GJB6 gene [5–9]. The
other two are private mutations, one of which (.930 kb) deletes
both GJB2 and GJB6 [11] and the other (del(chr13:19,837,343–
19,968,698) does not affect either gene and is located upstream of
GJB6 [10,12] (Fig 1).
We have recently reported that the larger of the two most
common deletions del(GJB6-D13S1830), disrupts human GJB2
expression at the transcriptional level in a allele-specific manner
[13], presumably by removing one or more cis-regulatory elements
located within the deleted region, which are as yet obscure. Given
the large proportion (up to ,13% in the USA [14]) of individuals
left with only one recessive GJB2 mutation after genetic testing
instead of the two expected, it seems plausible that some of the
unidentified mutations could be cis-regulatory in nature and would
be located outside the transcribed region.
The goal of this study was to determine whether the smaller and
less common del(GJB6-D13S1854) deletion, similar to del(GJB6-
D13S1830), disrupts human GJB2 expression at the transcriptional
level, which would lend further support to the putative presence of
regulatory element(s) upstream of GJB6. It has been assumed that
del(GJB6-D13S1854) and del(GJB6-D13S1830) would affect GJB2
expression similarly, however until now this has never been
demonstrated. Our study also sought to narrow down the region
were the supposed cis-regulatory element(s) may be located, based
on the fact that del(GJB6-D13S1854) is ,77 kb smaller than
del(GJB6-D13S1830) and that it is included within that deletion.
In order to investigate the relative abundance of GJB2 transcripts
from each allele, allele-specific analyses based on reverse-
transcriptase PCR (RT-PCR) were conducted with RNA extract-
ed from buccal epithelial cells, which are known to express both
Cx26 and Cx30 [10,13]. In all three probands, each of whom
carried a different sequence variant in GJB2, the expression of
GJB2 from the chromosome bearing the del(GJB6-D13S1854)
deletion was virtually absent (Table 1).
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Study subjects
Three controls with neither del(GJB6-D13S1854) nor del(GJB6-
D13S1830) and five probands were included in this study. Three
of the affected individuals were of Colombian origin (CE1, CE2
and CE3) as were two of the controls (CTR2 and CTR3). One
proband (CE1) was homozygous for del(GJB6-D13S1830), one
carried del(GJB6-D13S1830) and a GJB2 mutation in trans (CE2),
and three were compound heterozygous for del(GJB6-D13S1854)
and a GJB2 mutation in trans (CE3, CE4 and CE5). This study was
approved by the Stanford University institutional review board,
and written informed consents were obtained from all participants
(Table 1). The participating probands had hearing loss ranging
from moderate to profound. Control CTR1 had no identified
sequence changes; the other two controls were related to probands
and were heterozygous carriers of the GJB2 Ser199Phe (596C.T)
mutation. Control CTR2 was the father of proband CE2 and
control CTR3 was the mother of proband CE3. None of the
controls were affected. Direct sequencing and a restriction
fragment length polymorphism (PCR-RFLP) assay identified or
confirmed all sequence changes.
RT-PCR
Total RNA was isolated from buccal epithelium cells as
previously described [13]. Briefly, cells were collected on CytosoftH
Plus brushes (CooperSurgical, Trumbull, CT) and immediately
submerged in RNAlaterH (Ambion, Austin, TX). Cells were spun
down and total RNA was extracted following the RNAeasy mini
kit protocol (Qiagen, Valencia, CA). cDNA synthesis was
performed according to the SuperScript III (Invitrogen, Carlsbad,
CA) reverse transcription method and a negative control to rule
out gDNA contamination was included for each sample. The
negative controls followed all procedure steps with the matching
samples and remained negative (data not shown). We used cDNA-
specific primers to avoid amplification from gDNA. First, a
forward primer in GJB2 exon 1 was paired with a reverse primer
in exon 2 to generate a 728 bp PCR product from the cDNA
template only [13,15]. These primers amplify a region enclosing
the whole GJB2 coding sequence (CDS) (Table 2, Fig 2A). ß-actin
primers specific for cDNA [16] were used as an RNA expression
control for the sample homozygous for the del(GJB6-D13S1830)
deletion (CE1, Table 1). Second, for evaluation in the presence of
the 35delG mutation we used primers designed by Wilch et al. and
Wilcox et al. [10,17], which were located in exons 1 and 2, as well.
These primers generated a smaller (139 bp) PCR product, also
however specific only to cDNA (Table 2, Fig 3A). Four ml cDNA
per 20 ml reaction and 40 amplification cycles were used for all the
PCR amplifications described above.
Allele-specific assays
Relative transcript abundance from each GJB2 allele was
estimated by RT-PCR and RFLP assays. In the instance of GJB2
change Gln80Pro (239A.C), the 728 bp amplicon from the GJB2
Figure 1. Map of the region on chromosome 13q11-12 disrupted by deletions. The ,365 kb DNA section encompasses three genes (dark
boxes), the breakpoints of the deletions (arrowheads) and their range (dashed lines). All elements are drawn approximately to scale. GJB6 and CRYL1
are impacted by three of the four deletions; however GJB2 is directly affected only by the largest deletion. del(GJB6-D13S1854) and del(GJB6-
D13S1830) are investigated in this study. The transcriptional start sites are shown by bent arrows.
doi:10.1371/journal.pone.0021665.g001
Table 1. Genotypes and phenotypes of study subjects.
Proband GJB2 variant(s) GJB6 variant(s) Phenotype
CE1 WT/WT D(GJB6-D13S1830)/D(GJB6-D13S1830) Profound hearing loss
CE2 S199F/WT D(GJB6-D13S1830)/WT Profound hearing loss
CE3 S199F/WT D(GJB6-D13S1854)/WT Profound hearing loss
CE4 Q80P/WT D(GJB6-D13S1854)/WT Severe hearing loss
CE5 35delG/WT D(GJB6-D13S1854)/WT Moderate to Severe hearing loss
Control GJB2 variant(s) GJB6 variant(s) Phenotype
CTR1 WT/WT WT/WT None
CTR2 S199F/WT WT/WT None
CTR3 S199F/WT WT/WT None
doi:10.1371/journal.pone.0021665.t001
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digestion of sequences which are similar but not identical to the
restriction enzyme’s unique recognition sequence). The variant
eliminates a single PvuII-HF restriction site, which yields an
undigested product (728 bp) instead of two fragments (451 and
277 bp) when this variant is absent (Table 2 and Fig 2A). Variant
Ser199Phe (596C.T) eliminates an AlwNI restriction enzyme
site, which limits digestion of the Ser199Phe allele product to two
fragments (527 bp and 201 bp), instead of three (527, 101 and
100 bp) for the wild-type allele (Table 2 and Fig 2A).
For the 35delG mutation, a mismatched reverse primer [10]
eliminates a BstNI restriction site from the 139 bp RT-PCR
product, and this allows differentiation between the mutant and
wild-type alleles. The digested wild-type allele is associated with
fragment sizes of 110 bp and 29 bp, whereas the amplicon
associated with the mutant allele remains undigested (Table 2 and
Fig 3A).
Restriction enzyme digestion
Digestion was performed as previously described [13]. In brief,
10 mL of PCR product was digested with 10 units of the applicable
restriction enzyme for two hours, according to the manufacturer’s
protocol (New England Biolabs, Beverly, MA). Conditions
conducive to star activity were avoided and high fidelity restriction
enzymes were chosen when available. Products were electropho-
resed on 3% agarose gels or on 3.5% NuSieve 3:1 agarose gels
(Lonza, Rockland, ME).
Sequence analysis of the basal promoter, exon 1 and the
GJB2 coding region
The basal promoter and exon 1 of the GJB2 gene of three
selected samples (CE4, CE5 and CTR1) were investigated for the
presence of mutations according to Matos et al. [18]. In brief, a
1009 bp GJB2 segment was amplified which included part of the
59 UTR, exon 1 and the donor splice site of intron 1. A 539 bp
segment from this amplicon was sequenced using a hemi-nested
forward primer and the same reverse primer. This sequenced
segment included the 128 bp proximal promoter region, exon 1
and its donor splice site. The GJB2 CDS, the flanking sequence of
intron 1 (including the acceptor splice site) and a fraction of the
39UTR were also sequenced for all participants.
Results
We determined the allele-specific expression of GJB2 in four
study subjects who were compound heterozygous for either
del(GJB6-D13S1854) or del(GJB6-D13S1830) and a mutation in
GJB2,i ntrans (Table 1). At least one parent of each proband was
genotyped for both GJB2 and GJB6 to confirm that the mutations
were indeed present on opposite alleles. We also analyzed the
allele-specific expression of GJB2 in a fifth individual (CE1) who
was homozygous for the del(GJB6-D13S1830) deletion. Based on
our previous results [13], this individual with profound hearing
loss was expected to not express GJB2 at all. The complete failure
to amplify the 728 bp segment from the GJB2 cDNA indeed
indicates the complete absence of GJB2 expression from both
del(GJB6-D13S1830) alleles (Fig 4). GJB2 expression from an
unaffected individual with no identified mutations in either GJB6
or GJB2 (CTR1) was used as a control and the 728 bp segment
was amplified as expected (Fig 4). cDNA-specific ß-actin
expression [16] was used for RNA expression control. Both
proband and control amplified the expected 626 bp segment,
confirming normal ß-actin expression (Fig 4).
Study participant CE2 inherited the del(GJB6-D13S1830)
deletion from his mother and the Ser199Phe mutation in GJB2
from his father (Fig 2B). In order to make possible the distinction
between the affected and wild-type GJB2 alleles, we performed
allele-specific restriction digestions. The complete and reproduc-
ible absence of the 100 and 101 bp bands associated with the wild-
type allele for Ser199Phe (CE2, Fig 2D) demonstrated a lack of
GJB2 expression from the del(GJB6-D13S1830) allele in this
proband. The presence of the 201 bp fragment associated with a
Ser199Phe allele confirms expression of the opposite GJB2 allele
(CE2, Fig 2D). Allele-specific expression results from an individual
with no detectable mutations in either GJB6 or GJB2 (CTR1) and
from the father of the proband who is a carrier of Ser199Phe
(CTR2) were used as controls and were amplified as well as
digested simultaneously with the sample from the proband
(Fig 2D). Both controls expressed the expected alleles.
To determine whether del(GJB6-D13S1854) has the same effect
on GJB2 expression as del(GJB6-D13S1830), we analyzed the
allele-specific expression of GJB2 in an unrelated individual who
carried the same GJB2 (Ser199Phe) mutation, with the smaller
GJB6 deletion (del(GJB6-D13S1854) ) in trans. Proband CE3
inherited the deletion from his father and the Ser199Phe mutation
from his mother (Fig 2C). Interestingly, in this case we detected
minimal residual expression of the wild-type GJB2 allele in cis with
the del(GJB6-D13S1854) deletion (not readily visible in the printed
figure , Fig 2D). Both alleles are distinctly expressed by the mother
of this proband (CTR3). All expression experiments were
performed at least four times (twice each from two separate
RNA preparations) and results were congruent.
To further elucidate whether these results reveal a consistent
regulatory effect of the del(GJB6-D13S1854) mutation, we
analyzed the allele-specific expression of GJB2 in another two
unrelated individuals who carried the same GJB6 deletion with
Table 2. PCR-RFLP used to distinguish GJB2 variants Gln80Pro (239A.C), Ser199Phe (596C.T) and 35delG.
Mutation Primer and sequence (59–39)
Product size
(bp) Restriction enzyme
Fragment sizes
(bp)
Q80P
aF1: TTCCTCCCGACGCAGAGCAA
bR1: GGGCAATGCGTTAAACTGGC
728 PvuII-HF Wt: 451+277
Mt: 728
S199F
aF1: TTCCTCCCGACGCAGAGCAA
bR1: GGGCAATGCGTTAAACTGGC
728 AlwNI Wt: 527+101+100
Mt: 527+201
35delG
cF: CGCAGAGACCCCAACGCCGAGA
dR: GCTGGTGGAGTGTTTGTTCACACCCGC
e
139 BstNI Wt: 110+29
Mt: 139
aRodriguez-Paris et al. [13].
bMueller et al. [15].
cWilch et al. [10].
dWilcox et al. [17].
eUnderscored base is mismatched to eliminate BstNI restriction enzyme site. Wt =
wild-type; Mt = Mutant.
doi:10.1371/journal.pone.0021665.t002
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PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e21665Figure 2. Allele-specific expression analysis for GJB2, based on Ser199Phe (596C.T) and Gln80Pro (239A.C). (A) Schematic design of
AlwNI and PvulI-HF digestion analysis. A 728 bp GJB2 cDNA amplicon was digested with AlwNI to distinguish Ser199Phe (S199F) from the wild-type
allele, or with PvulI-HF to distinguish Gln80Pro (Q80P). Bars indicate GJB2 exons. The translated region within exon 2 is shaded. The relative positions
of the GJB2 sequence changes (dotted arrows) and restriction sites (arrows) are indicated. Digestion fragment sizes are listed for both sequence
changes and the wild-type. (
#) and (*) indicate fragments unique to the wild-type alleles in cis with del(GJB6-D13S1830) or del(GJB6-D13S1854),
respectively. (B) Pedigree of proband CE2, who carries del(GJB6-D13S1830) in trans with Ser199Phe in GJB2. (C) Pedigree of proband CE3, who carries
the del(GJB6-D13S1854) deletion in trans with Ser199Phe in GJB2. (D) GJB2 expression analysis based on the Ser199Phe sequence variant. The
Ser199Phe mutation prevents AlwNI from digesting the original 201 bp fragment into a 101 and a 100 bp fragment, as illustrated in A. The digested
100 and 101 bp bands represent the wild-type allele and are undetectable in proband CE2 and almost entirely absent (the very faint remaining band
is not visible on the printed picture) in proband CE3, indicating a complete lack of GJB2 expression from the del(GJB6-D13S1830) allele and an almost
a complete lack from the del(GJB6-D13S1854) carrying chromosome. (E) Allele-specific expression analysis for GJB2, based on Gln80Pro (239A.C).
This mutation prevents PvulI-HF from digesting the 728 bp RT-PCR product in proband CE4. The digested bands represent the wild-type allele, which
are almost undetectable in proband CE4 indicating a nearly complete lack of GJB2 expression from the del(GJB6-D13S1854) carrying chromosome. M
= marker; ud = undigested, no restriction enzyme added; d = digested, restriction enzyme added.
doi:10.1371/journal.pone.0021665.g002
Figure 3. Allele-specific expression analysis for GJB2, based on 35delG. (A) A schematic representation (not to scale) of BstNI digestion
analysis [10]. A 139 bp PCR product was amplified from GJB2 cDNA. Bars indicate GJB2 exons. The translated region within exon 2 is shaded. GJB2
mutation 35 delG is indicated (dotted arrows), as is the restriction site (arrow). The mutation eliminates a single BstNI restriction enzyme site. (B) BstNI
digestion of the product amplified from proband CE5 yields an undigested 139 bp band from the 35delG allele, but the 110 bp digestion product
expected from the wild-type allele is virtually absent. The wild-type control (CTR1) yields the expected 110 bp band. M= marker; ud = undigested,
no restriction enzyme added; d = digested, restriction enzyme added.
doi:10.1371/journal.pone.0021665.g003
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proband CE4 was heterozygous for Gln80Pro (239A.C). The
allele-specific expression assay demonstrated the 728 bp uncut
band from that allele, but revealed only minimal residual
expression at the wild-type fragments (CE4, Fig 2E). Thus, the
GJB2 transcript from the allele in cis with del(GJB6-D13S1854) is
almost entirely absent (Fig 2E). The respective control in this case
was a sample from an individual without GJB2 mutations (CTR1),
which clearly expressed only the expected wild-type allele. The
third proband with del(GJB6-D13S1854) had moderate to severe
hearing loss and was compound heterozygous with 35delG in the
GJB2 gene, in trans. Again, the allele-specific assay virtually lacked
the 110 bp fragment associated with the wild-type allele,
substantiating the almost complete down-regulation of GJB2
expression from the chromosome with del(GJB6-D13S1854) (CE5,
Fig 3B). The control (CTR1) on the other hand clearly exhibited
the expected transcript.
We sequenced GJB2 exon 1, its splice sites and the proximal
promoter region in probands CE4 and CE5 as well as in control
CTR1, to confirm that the allele-specific loss of GJB2 expression
was related to the GJB6 deletions and not to another mutation on
the same allele. No sequence changes were detected in the
analyzed regions. Furthermore, all primer binding sites were
investigated for potential sequence changes to minimize the
possibility for bias in PCR amplification due to differences in
primer binding affinity. No sequence changes in primer binding
sites were identified.
Discussion
The main purpose of this study was to demonstrate an effect on
GJB2 expression by del(GJB6-D13S1854), which is internal to the
larger and more prevalent del(GJB6-D13S1830) deletion, which
we studied previously [13]. Secondarily, we aimed to refine the
location of the GJB2 regulatory element(s) that is/are hypothesized
to be within the deleted regions. Using immunostaining, a cell-
specific loss of Cx26 expression was observed in the sweat glands
of an individual compound heterozygous for 35delG in GJB2 and
del(GJB6-D13D1830) in GJB6. The functional effect on Cx26
protein pointed to the disruption of a putative cis-regulatory
element which appears to function with cell-type specificity within
the sweat gland [19]. Until recently [12,13], however, no more
direct support of the existence or effects of such elements was
reported.
Deletion del(GJB6-D13S1854) is one of four reported DFNB1
deletions (Fig 1), of which only one (.920 kb deletion) directly
affects the GJB2 gene [11]. Another pathogenic DFNB1 deletion
was identified entirely upstream from GJB6 (Fig 1) in a large
kindred of German extraction. This ,131 kb deletion segregated
with profound deafness when in trans with 35delG in GJB2. Allele-
specific expression demonstrated markedly reduced expression for
GJB2 as well as GJB6, with under-representation of the allele with
the deletion [10,12]. This deletion remains unique to this family
[12]. del(GJB6-D13S1854) is about 77 kb smaller than the
,309 kb del(GJB6-D13S1830), which includes the former. It has
been assumed but not previously demonstrated that del(GJB6-
D13S1854) impairs GJB2 expression in an allele-specific manner
similar to what has been reported for del(GJB6-D13S1830). We
determined the effect on GJB2 expression by using qualitative
allele-specific RT-PCR analyses to assess the relative abundance of
GJB2 transcript from both alleles. The studies were performed on
readily accessible buccal epithelium, which expresses both Cx26
and Cx30 and has been postulated to contain one or more
functional regulatory elements that control expression of both
proteins [10,12,13]. Three probands were identified who carried
del(GJB6-D13S1854) and each had different mutations in the
GJB2 gene, in trans (Table 1). Their hearing phenotypes ranged
from moderate to profound and were not obviously correlated
with the severity of the GJB2 change (Table 1). In contrast to the
previously reported and additional, currently included, individuals
with the larger del(GJB6-D13S1830) in whom we could not detect
any GJB2 expression from that allele (CE1 and CE2; [13]), there
was reproducibly suppressed and barely detectable low residual
GJB2 expression from the chromosomes which carried del(GJB6-
D13S1854) (CE3, CE4 and CE5, Figs 2 and 3). The controls
expressed both alleles normally, as expected (CTR2 and CTR3,
Fig 2D, and CTR1, Fig 3B). This interesting difference between
the two deletions supports the putative presence of multiple
regulatory elements upstream of GJB6. Because the smaller
deletion maintains at least some residual GJB2 expression one
could assume that some such regulatory or locus-control elements
are not deleted with the 77 kb shorter del(GJB6-D13S1854).
It is as yet unclear how, exactly, a lack of transcription results in
a hearing loss phenotype and to what extent partial or complete
deletion of the GJB6 gene contributes to this phenotype in
humans. However, some such processes have been studied in some
of the connexins and are clinically relevant [20]. Co-regulation of
the two connexins has been explored by immunohistochemistry as
well as quantitative PCR analysis in Cx30 knock-out mouse
Figure 4. GJB2 expression of a del(GJB6-D13S1830) homozy-
gous patient. PCR amplification was performed after reverse
transcription using primers specific for GJB2 cDNA (F1 and R1, Table 2
and Fig 2A). The wild-type control CTR1 amplified a 728 bp segment
characteristic for GJB2 while del(GJB6-D13S1830) homozygous patient
CE1 did not express that band at all. ß-actin was used as an RNA
expression control. Both samples amplified the expected 626 bp ß-actin
band specific for cDNA.
doi:10.1371/journal.pone.0021665.g004
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non-sensory cochlear cells, which could be overcome by over-
expression of Cx30 after transduction with bovine adeno-
associated virus. The expression of Cx26 and Cx30 in mouse
cultures was inter-related and reciprocal, because down-regulation
of Cx26 in cultures of a mouse model with ablation of Cx26
negatively impacted the expression of Cx30 as well as the
communication between cells [21].
In summary, we conclude that the hearing loss in probands with
the del(GJB6-D13S1854) deletion (and a heterozygous mutation in
GJB2) results from a lack of functional Cx26 protein similar to the
patients bearing larger deletion del(GJB6-D13S1830) (Figs 2 and
4, [13]). Our results are supportive of the presence of GJB2 cis-
regulatory element(s) upstream GJB6 and narrow down the
location of those putative element(s) that most powerfully impact
GJB2 expression.
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